Class 4 Medicines Defect Information: Zoledronic acid 5mg solution for infusion (MDR 51-03/19)
- The problem
- Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from a batch of Zoledronic acid 5mg solution for infusion contain a Patient Information Leaflet for Temozolomide 180mg Capsules.
- What to do
- Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Company name
Sun Pharmaceutical Industries Europe BV
Product description
Zoledronic acid 5mg solution for infusion (PL 31750/0054)
- Batch number: JKT1576A
- Expiry date: 30 April 2020
- Pack size: 1 x 100ml
- First distributed: 12 October 2018
Brief description of the problem
Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from the above batch contain a Patient Information Leaflet (PIL) for Temozolomide 180mg Capsules.
Advice for healthcare professionals
When dispensing the above batch, please check the Patient Information Leaflet (PIL). If the pack contains the wrong PIL, please remove it and provide a copy of the correct PIL. This can be downloaded via the following link:
https://www.medicines.org.uk/emc/product/5242/pil
Further information
For any enquiries, please contact Ranbaxy / Sun Pharmaceuticals customer services team:
Email: cserv.uk@sunpharma.com
Tel: 020 8848 5050
Download the document
Drug alert: Zoledronic acid 5mg solution for infusion (MDR 51-03/19)
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter.
Updated 4 April 2019. This page summarises an official notice. Details can change – always follow the official notice.